Rosiglitazone: seeking a balanced perspective

Lancet. 2007 Jun 2;369(9576):1834. doi: 10.1016/S0140-6736(07)60787-9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Myocardial Infarction / chemically induced*
  • Periodicals as Topic
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone